-
BRIDGING HEALTHCARE DISPARITIES: A SYSTEMATIC REVIEW OF HEALTHCARE ACCESS FOR DISABLED INDIVIDUALS IN RURAL AND URBAN AREAS
Mar 18, 2026, 21:38 PM -
DISTANCE FROM HEALTH CARE FACILITY AND OTHER VARIABLES IMPACT TIME TO CELIAC DISEASE DIAGNOSIS
Mar 18, 2026, 21:38 PM -
USE OF REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR) IN PROSTATE CANCER (PC) ENABLES ON-DEMAND ACCESS TO PIVOTAL CLINICAL TRIAL EVIDENCE
Mar 18, 2026, 21:38 PM -
COMPARABILITY OF OPEN AND CLOSED CLAIMS DATA FOR HEALTHCARE RESOURCE UTILIZATION ASSESSMENT IN ACUTE ISCHEMIC STROKE
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF PERITONEAL DIALYSIS VERSUS HEMODIALYSIS FOR END-STAGE RENAL DISEASE IN TURKEY
Mar 18, 2026, 21:38 PM -
COST COMPARISON OF ATEZOLIZUMAB IN CANADA FOR THE FIRST-LINE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS WITH HIGH PROGRAMMED DEATH-LIGAND 1 EXPRESSION
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN OF INCIDENT BRAIN METASTASES IN MEDICARE BENEFICIARIES WITH ALK+ METASTATIC NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
AI/ML IN HTA EVIDENCE SYNTHESIS: WHERE DO WE STAND TODAY?
Mar 18, 2026, 21:38 PM -
HOSPITAL ADMISSIONS AND COMORBIDITY PROFILES OF HYPERTENSIVE PATIENTS IN CHILE
Mar 18, 2026, 21:38 PM -
CAN A GENERATIVE PATIENT JOURNEY FOUNDATION MODEL ALLEVIATE THE BURDEN OF CANCER SCREENING?
Mar 18, 2026, 21:38 PM -
THE BUDGET IMPACT OF INTRODUCING ZONGERTINIB INTO THE FORMULARY FOR TREATMENT-NAÏVE AND PRETREATED HER2-MUTANT ADVANCED NSCLC IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
FACTORS EXPLAINING HPV VACCINE COMPLETION AMONG MEDICAID VACCINE INITIATORS IN KENTUCKY FROM 2010 TO 2022: AN APPLICATION OF GRADIENT BOOSTING
Mar 18, 2026, 21:38 PM -
EFFECT OF GLP 1 RECEPTOR AGONISTS ON RESPIRATORY OUTCOMES: AN INVERSE DISPROPORTIONALITY ANALYSIS OF FAERS DATA AND SYSTEMATIC REVIEW WITH META-ANALYSIS OF TYPE 2 DIABETES MELLITUS CLINICAL TRIALS
Mar 18, 2026, 21:38 PM -
HOW THE EU JOINT CLINICAL ASSESSMENT UNCERTAINTIES IMPACT US PHARMACEUTICAL MARKET ACCESS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS WITH REAL-WORLD DATA REUSING BRAZILIAN HEALTH SYSTEM DATABASES: A CASE STUDY IN BREAST CANCER
Mar 18, 2026, 21:38 PM -
PATIENT ATTITUDES TO SHARED DECISION-MAKING AND INNOVATIONS IN MUSCLE INVASIVE BLADDER CANCER: A MULTI-COUNTRY FOCUS GROUP
Mar 18, 2026, 21:38 PM -
CHARACTERIZING AUTOIMMUNE FLARES IN REAL WORLD SETTINGS AMONG INDIVIDUALS WITH RHEUMATOID ARTHRITIS ENROLLED IN AN ONLINE COMMUNITY
Mar 18, 2026, 21:38 PM -
GENERAL-PURPOSE VS HEOR-SPECIFIC GENERATIVE AI IN RARE DISEASE MODELING: A DUCHENNE MUSCULAR DYSTROPHY CASE STUDY
Mar 18, 2026, 21:38 PM -
COMBINING DISCRETE CHOICE EXPERIMENT AND CONTINGENT VALUATION TO ESTIMATE WILLINGNESS-TO-PAY FOR LYME DISEASE VACCINE ATTRIBUTES IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
AUTOMATING MODEL PARAMETERISATION FOR HEALTH ECONOMIC MODELS: VALIDATION OF A GEN-AI RAG PIPELINE
Mar 18, 2026, 21:38 PM
